Posted by Michael Wonder on 23 May 2017
Post-market review of ezetimibe – revised draft report
23 May 2017 - Public consultation on the revised draft report to the PBAC of the post-market review of ezetimibe is now open.
Interested organisations and individuals are invited to provide a submission addressing the Revised Draft Report. To make a submission please go to the Public Consultation page.
The public submission process will be open for 2 weeks and will close at 5 pm Tuesday, 6 June 2017.
